Nanalysis Scientific Corp.
NSCIF
Rank in Stocks
#28365
Nanalysis Scientific Corp. develops, manufactures, and sells magnetic resonance... Nanalysis Scientific Corp. develops, manufactures, and sells magnetic resonance technology products in Canada, the United States, Europe, Asia, and internationally. The company operates through Scientific Equipment and Security Services segment. It offers nuclear magnetic resonance (NMR) spectrometers; magnetic resonance test, and measurement and diagnostic system; 60-NMR platform; 100-NMR platform; 60-TEACH Platform; QUAD NMR Console; and Cameleon 4 console, a compact alternative to facilitate MRI for teaching. The company also provides software products, such as NMRGui, an user interface for data acquisition and processing of benchtop NMR product; SPINit MR software platform to facilitate data acquisition, processing, and pulse programming; and NMRFx platform that offers a suite of software tools to streamline and automate MR data analysis and management. In addition, it offers security service, including preventive and on-call maintenance services, scheduled preventative maintenance work, corrective maintenance work, installation and upgrade projects for detection and general security equipment; other technical maintenance services; and installation and maintenance services for commercial security equipment, such as scanning devices, metal detectors, detection equipment, and other general security equipment. It serves pharmaceutical, biotechnology, nutraceutical, chemical, security, food, oil and gas, materials, life science, medical, and educational industries. The company is headquartered in Calgary, Canada.
Share Price
$0.075
Last synced: 2026-11-13
Market Cap
$10.39M
Change (1 day)
-7.41%
Change (1 year)
-44.57%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Nanalysis Scientific Corp. (NSCIF)
Category
Healthcare
Operating Margin for Nanalysis Scientific Corp. (NSCIF)
Operating Margin as of November 2026 TTM: -5.03%
According to Nanalysis Scientific Corp.'s latest financial reports, its current operating margin (TTM) is -5.03%. At the end of 2025 the company had an operating margin of -9.38%.
Operating Margin history for Nanalysis Scientific Corp. from 2016 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -5.03% | -46.38% |
| 2025 | -9.38% | 23.91% |
| 2024 | -7.57% | -81.46% |
| 2023 | -40.82% | 2.23% |
| 2022 | -39.93% | 438.14% |
| 2021 | -7.42% | -83.92% |
| 2020 | -46.15% | -6,788.41% |
| 2019 | 0.69% | -87.45% |
| 2018 | 5.50% | -73.96% |
| 2017 | 21.12% | 420.20% |
| 2016 | 4.06% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 18.91% | -103.76% |
IE
|
|
| 10.95% | -102.18% |
CN
|
|
| 25.26% | -105.02% |
CH
|
|
| 13.54% | -102.69% |
CH
|
|
| 38.62% | -107.68% |
CN
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Nanalysis Scientific Corp.'s operating margin
What is Nanalysis Scientific Corp.'s operating margin?
Nanalysis Scientific Corp.'s operating margin is -5.03%, as of Nov 2026.
What was Nanalysis Scientific Corp.'s operating margin in 2025?
In 2025, Nanalysis Scientific Corp.'s operating margin was -9.38%, compared with -7.57% in 2024.
How has Nanalysis Scientific Corp.'s operating margin changed since 2020?
From 2020 to 2025, Nanalysis Scientific Corp.'s operating margin was highest in 2021 (-7.42%) and lowest in 2020 (-46.15%).
How does Nanalysis Scientific Corp.'s operating margin compare with similar companies?
Nanalysis Scientific Corp.'s operating margin (-5.03%) is lower than that of all 5 similar companies listed above. The highest among them is Jafron Biomedical Co.,Ltd., with 38.62%.